The Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes

NCT04219124 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: IMP oral tablet
DRUG: Placebo oral tablet

Sponsor

University of Leicester

Collaborators

[object Object]
[object Object]